Ann-Kathrin Eisfeld, MD, discusses factors to consider when deciding whether to start treatment right away or wait for molecular testing results in patients with acute myeloid leukemia.
Four students from The Ohio State University have been recognized by the Barry M. Goldwater Scholarship and Excellence in Education Program.Isaiah BoatengIsaiah BoatengIsaiah Boateng, Defne Ceyhan, Devi Dheekshita Nelakurti and Anya Phillips were all
Ann-Kathrin Eisfeld, MD, discusses recent changes to the classification of acute myeloid leukemia, and potential challenges accompanying these new guidelines.
During an OncLive® workshop titled Key Updates in the Management of Acute Myeloid Leukemia and Their Application in Clinical Practice, moderated by Naval Daver, MD, faculty reviewed updates to the classification of acute myeloid leukemia and its effects on the treatment paradigm and provided insight on the management of adverse-risk and secondary acute myeloid leukemia.